PubMed

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis.

van der Heijde DM, Revicki DA, Gooch KL, Wong RL, Kupper H, Harnam N, Thompson C, Sieper J; ATLAS Study Group.

Arthritis Res Ther. 2009;11(4):R124. Epub 2009 Aug 17.PMID: 19686597 [PubMed - indexed for MEDLINE]Related articlesFree article

Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.

Davis JC Jr, Revicki D, van der Heijde DM, Rentz AM, Wong RL, Kupper H, Luo MP.

Arthritis Rheum. 2007 Aug 15;57(6):1050-7.PMID: 17665483 [PubMed - indexed for MEDLINE]Related articlesFree article

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).

Revicki DA, Luo MP, Wordsworth P, Wong RL, Chen N, Davis JC Jr; ATLAS Study Group.

J Rheumatol. 2008 Jul;35(7):1346-53. Epub 2008 May 15.PMID: 18484692 [PubMed - indexed for MEDLINE]Related articles

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.

van der Heijde D, Schiff MH, Sieper J, Kivitz AJ, Wong RL, Kupper H, Dijkmans BA, Mease PJ, Davis JC Jr; ATLAS Study Group.

Ann Rheum Dis. 2009 Jun;68(6):922-9. Epub 2008 Aug 13.PMID: 18701556 [PubMed - indexed for MEDLINE]Related articlesFree article

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.PMID: 17651658 [PubMed - indexed for MEDLINE]Related articlesFree article

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial.

Gladman DD, Mease PJ, Cifaldi MA, Perdok RJ, Sasso E, Medich J.

Ann Rheum Dis. 2007 Feb;66(2):163-8. Epub 2006 Oct 17.PMID: 17046964 [PubMed - indexed for MEDLINE]Related articlesFree article

[Measurement of quality of life in patients with active ankylosing spondylitis being treated with infliximab-a comparison of SF-36 and SF-12]

Haibel H, Niewerth M, Brandt J, Rudwaleit M, Listing J, Sieper J, Braun J.

Z Rheumatol. 2004 Oct;63(5):393-401. German. PMID: 15517300 [PubMed - indexed for MEDLINE]Related articles

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.

Revicki DA, Menter A, Feldman S, Kimel M, Harnam N, Willian MK.

Health Qual Life Outcomes. 2008 Oct 2;6:75.PMID: 18831744 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P.

Am J Gastroenterol. 2008 Dec;103(12):3132-41. Epub 2008 Oct 3. Erratum in: Am J Gastroenterol. 2009 Jul;104(7):1894. PMID: 18853973 [PubMed - indexed for MEDLINE]Related articles

Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.

Boonen A, Patel V, Traina S, Chiou CF, Maetzel A, Tsuji W.

J Rheumatol. 2008 Apr;35(4):662-7. Epub 2008 Feb 15.PMID: 18278836 [PubMed - indexed for MEDLINE]Related articles

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis.

van der Heijde D, Pangan AL, Schiff MH, Braun J, Borofsky M, Torre J, Davis JC Jr, Wong RL, Kupper H, Collantes E; ATLAS Study Group.

Ann Rheum Dis. 2008 Sep;67(9):1218-21. Epub 2007 Dec 4.PMID: 18056755 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.

Revicki DA, Willian MK, Menter A, Gordon KB, Kimball AB, Leonardi CL, Langley RG, Kimel M, Okun M.

J Dermatolog Treat. 2007;18(6):341-50.PMID: 18058494 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.

Arthritis Rheum. 2005 Feb;52(2):582-91.PMID: 15692973 [PubMed - indexed for MEDLINE]Related articlesFree article

Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.

Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, Thomson GT, Beaulieu A, Choquette D, Maksymowych WP.

Arthritis Rheum. 2007 Dec;56(12):4005-14.PMID: 18050198 [PubMed - indexed for MEDLINE]Related articlesFree article

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J.

Arthritis Rheum. 2003 Jun;48(6):1667-75.PMID: 12794835 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

van der Heijde D, Salonen D, Weissman BN, Landewé R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R; Canadian (M03-606) study group; ATLAS study group.

Arthritis Res Ther. 2009;11(4):R127. Epub 2009 Aug 24.PMID: 19703304 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis.

Maksymowych WP, Gooch KL, Wong RL, Kupper H, van der Heijde D.

J Rheumatol. 2010 Feb;37(2):385-92. Epub 2009 Dec 1.PMID: 19955052 [PubMed - in process]Related articles

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC Jr; ATLAS Study Group.

Arthritis Rheum. 2006 Jul;54(7):2136-46.PMID: 16802350 [PubMed - indexed for MEDLINE]Related articlesFree article

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial.

Shikiar R, Heffernan M, Langley RG, Willian MK, Okun MM, Revicki DA.

J Dermatolog Treat. 2007;18(1):25-31.PMID: 17365264 [PubMed - indexed for MEDLINE]Related articles

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT).

Mease PJ, Ory P, Sharp JT, Ritchlin CT, Van den Bosch F, Wellborne F, Birbara C, Thomson GT, Perdok RJ, Medich J, Wong RL, Gladman DD.

Ann Rheum Dis. 2009 May;68(5):702-9. Epub 2008 Aug 6.PMID: 18684743 [PubMed - indexed for MEDLINE]Related articlesFree article